{"uri": "eng-9431865", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Pfizer", "type": "wiki", "score": 100, "label": {"eng": "Pfizer"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 51, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Vaccine", "type": "wiki", "score": 29, "label": {"eng": "Vaccine"}}, {"uri": "http://en.wikipedia.org/wiki/Coronavirus", "type": "wiki", "score": 25, "label": {"eng": "Coronavirus"}}], "eventDate": "2024-03-25", "totalArticleCount": 5, "title": {"eng": "Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?"}, "summary": {"eng": "Cathie Wood and high dividend yields go together like... well, it's hard to finish that sentence because they don't go together at all. Wood and her Ark Invest funds are known for investing in innovative growth stocks, not stocks with exceptionally attractive dividends.\n\nBut Pfizer (NYSE: PFE) stood out as an exception to the rule. Wood initiated a position in the big drugmaker for her Ark Genomic Innovation ETF in 2021. However, she has sold this high-yield dividend stock in recent months. Shoul"}, "location": null, "categories": [{"uri": "dmoz/Business/Investing", "label": "dmoz/Business/Investing", "wgt": 59}, {"uri": "dmoz/Business/Investing/Stocks_and_Bonds", "label": "dmoz/Business/Investing/Stocks and Bonds", "wgt": 62}, {"uri": "dmoz/Society/Issues/Business", "label": "dmoz/Society/Issues/Business", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 84}], "articleCounts": {"eng": 5}, "sentiment": 0.0980392156862746, "wgt": 449020800, "relevance": 1}